These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 3301245)
1. Maintenance therapy for prevention of recurrent peptic ulcers. Berardi RR; Savitsky ME; Nostrant TT Drug Intell Clin Pharm; 1987 Jun; 21(6):493-501. PubMed ID: 3301245 [TBL] [Abstract][Full Text] [Related]
2. Medical treatment of peptic ulcers. Deveney CW; Deveney KE Surg Annu; 1985; 17():219-33. PubMed ID: 3883541 [TBL] [Abstract][Full Text] [Related]
3. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs. ten Wolde S; Dijkmans BA; Janssen M; Hermans J; Lamers CB Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962 [TBL] [Abstract][Full Text] [Related]
4. Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine. Libeskind M Scand J Gastroenterol Suppl; 1983; 83():69-70. PubMed ID: 6356324 [TBL] [Abstract][Full Text] [Related]
5. Drugs for the prevention of peptic ulcer recurrence. Piper DW Drugs; 1983 Nov; 26(5):439-53. PubMed ID: 6315333 [TBL] [Abstract][Full Text] [Related]
6. The other option in peptic ulcer therapy. Halter F S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932 [TBL] [Abstract][Full Text] [Related]
7. Role of protective drugs in the prevention of ulcer relapse. Ota S; Terano A J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147 [TBL] [Abstract][Full Text] [Related]
8. Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment. Hui WM; Lam SK; Lok AS; Ng MM; Lai CL Am J Med; 1992 Mar; 92(3):265-74. PubMed ID: 1546725 [TBL] [Abstract][Full Text] [Related]
10. Effect of lansoprazole on peptic ulcers. Ohashi T; Sakata J; Haraguchi Y; Eto T J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350 [TBL] [Abstract][Full Text] [Related]
11. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate. Marks IN; Lucke W; Wright JP; Girdwood AH J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353 [TBL] [Abstract][Full Text] [Related]
12. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Campoli-Richards DM; Clissold SP Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864 [TBL] [Abstract][Full Text] [Related]
14. Review of peptic ulcer maintenance trials. Robinson M Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657 [TBL] [Abstract][Full Text] [Related]
15. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases. Langtry HD; Grant SM; Goa KL Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505 [TBL] [Abstract][Full Text] [Related]